Biolegend, 400612, APC Rat IgG2b, κ Isotype Ctrl Antibody, 100μg

The isotype of RTK4530 immunoglobulin is rat IgG2b, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
100μg
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Trinitrophenol + KLH
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested ICFC - Verified
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control. Use at concentrations comparable to those of the specific antibody of interest.
Excitation Laser: Red Laser (633 nm)
Application Notes: The RTK4530 immunoglobulin is useful as an isotype-matched control (for the relevant formats) for Western blotting, immunoprecipitation, immunohistochemistry, functional assay, and immunofluorescence microscopy. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 400643, 400644, 400671, 400672, 400675, and 400676) as negative control.
Application References(PubMed link indicates BioLegend citation): Cervantes-Barragan L, et al. 2007. Blood 109:1131. Zeiser R, et al. 2007. Blood 109:2225. Sasaki K, et al. 2008. J. Immunol. 181:104. PubMed Duan J, et al. 2008. P. Natl. Acad. Sci. USA 105:5183. PubMed Yi H, et al. 2009. Blood 113:5819. PubMed Schafeer JS, et al. 2010. J. Leukocyte Biol. 87:301. PubMed Lei GS, et al. 2015. Infect Immun. 83:572. PubMed Richards J, et al. 2015. Mol Cell Cardiol. 79:21. PubMed
Product Citations: Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed Combes F, et al. 2018. Neoplasia. 20:848. PubMed Elbasiony E, et al. 2023. NPJ Aging. 9:2. PubMed Gu T, et al. 2023. Front Immunol. 14:1145028. PubMed Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed Fu JF, et al. 2022. Neoplasia. 29:100802. PubMed Ringelstein-Harlev S, et al. 2023. Eur J Haematol. 110:371. PubMed Market M, et al. 2022. Int J Mol Sci. 23: . PubMed Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed Hattori Y, et al. 2023. Cell Rep. 42:112092. PubMed Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Machata S, et al. 2021. Front Immunol. 11:565869. PubMed Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed Yamane M, et al. 2020. FASEB J. 34:10778. PubMed Fu Y, et al. 2020. Sci Rep. 10:9027. PubMed Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed Liu H, et al. 2020. J Immunol. 1954:204. PubMed Marangoni F, et al. 2021. Cell. . PubMed Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed Zhang X, et al. 2020. J Immunol. 205:1743. PubMed Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Yewdell WT, et al. 2020. Immunity. 53(5):952-970.e11. PubMed Market M, et al. 2020. Front Immunol. 1.127083333. PubMed Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed Yang H, et al. 2022. Nutrients. 14:. PubMed Ross EC, et al. 2021. Cell Mol Life Sci. 78:5197. PubMed Andersen S, et al. 2013. Cytokine. 64:54. PubMed Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed Wang X, et al. 2018. Cell Death Dis. 9:578. PubMed LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed Kumar B, et al. 2022. Sci Adv. 8:eabh3375. PubMed Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed Gu B, et al. 2020. Molecular Cell. 80(4):699-711.e7. PubMed Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Matsubara Y, et al. 2014. Sci Rep. 4:5043. PubMed Yang T, et al. 2022. Antioxidants (Basel). 11:. PubMed Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed Deng Q, et al. 2021. Gut Microbes. 13:1. PubMed Christoforou N, et al. 2013. PLoS One. 8:65963. PubMed Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed Farhat AM, et al. 2021. Cell Reports. 35(4):109044. PubMed Schroder WA, et al. 2019. Sci Rep. 9:12421. PubMed Rousset F, et al. 2018. Mol Ther Nucleic Acids. 14:351. PubMed Piirainen S, et al. 2021. Glia. 69:2459. PubMed Luna-Yolba R, et al. 2021. Cancers (Basel). 13: . PubMed Allman W, et al. 2016. PLoS One. 11: 0154518. PubMed Gross KM, et al. 2019. Cell Rep. 28:394. PubMed Zhu Y et al. 2017. The Journal of Neuroscience. 37(9):2362-2376 . PubMed Harada Y, et al. 2019. Pain. 160:2050. PubMed Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
RRID: AB_326555 (BioLegend Cat. No. 400611) AB_326556 (BioLegend Cat. No. 400612)
Gene ID: NA
Clone: RTK4530
Regulatory Status: RUO
Isotype: Rat IgG2b, κ